Shanrong Biotechnology is selling for under 3.49 as of the 5th of February 2025; that is 66.19% increase since the beginning of the trading day. The stock's last reported lowest price was 2.11. Shanrong Biotechnology has 48 percent odds of going through some form of financial distress in the next two years but had a very good returns during the last 90 days. The performance scores are derived for the period starting the 11th of April 2024 and ending today, the 5th of February 2025. Click here to learn more.
Shanrong Biotechnology Corp. operates as a project management and executive consulting company. Shanrong Biotechnology Corp. is based in Beverly Hills, California. Shanrong Biotechnology operates under Shell Companies classification in the United States and is traded on OTC Exchange.. The company has 380.98 K outstanding shares. More on Shanrong Biotechnology Corp
Shanrong Biotechnology Corp [SRBT] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 380.98 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Shanrong Biotechnology's market, we take the total number of its shares issued and multiply it by Shanrong Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Shanrong Biotechnology conducts business under Financial Services sector and is part of Shell Companies industry. The entity has 380.98 K outstanding shares.
Shanrong Biotechnology Corp currently holds about 30.87 K in cash with (31.75 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Check Shanrong Biotechnology Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Shanrong Biotechnology without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Efficient Frontier Now
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
When running Shanrong Biotechnology's price analysis, check to measure Shanrong Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanrong Biotechnology is operating at the current time. Most of Shanrong Biotechnology's value examination focuses on studying past and present price action to predict the probability of Shanrong Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanrong Biotechnology's price. Additionally, you may evaluate how the addition of Shanrong Biotechnology to your portfolios can decrease your overall portfolio volatility.